HRMY
HRMY
NASDAQ · Pharmaceuticals

Harmony Biosciences Holdings

$31.83
+0.57 (+1.82%)
As of May 9, 1:29 AM ET ·
Analyst Consensus
Buy
17
Analysts
High
Coverage
Buy 11 65%
Hold 5 29%
Sell 1 6%
Price Target
Analyst Price Target +193.8% upside
Low Target $67.60
Average Target $93.52
High Target $113.52
Current Price $31.83
Current
$31.83
Target
$93.52
$67.60 $93.52 avg $113.52
Scenario Analysis
Bear Case
$67.60
112.4%
Low target
Base Case
$93.52
+193.8%
Avg target
Bull Case
$113.52
+256.6%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$40.87
-22.1% from high
52-Week Low
$25.52
+24.7% from low
50-Day SMA
$37.42
-14.9% vs SMA
200-Day SMA
$34.21
-7.0% vs SMA
RSI (14)
38.4
Neutral
Target vs 52W High
$93.52
+128.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%